MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind placebo-controlled study assessed the safety and effectiveness
of MDMA-assisted therapy among people with chronic, treatment-resistant PTSD, including
veterans. The study enrolled 23 participants. Participants were assigned to receive either
therapy with a single divided dose of MDMA or lactose placebo during two blinded experimental
sessions spaced three to five weeks apart during Stage 1 of the study. During these
experimental sessions, participants received an initial dose of 125 mg of MDMA followed by a
supplemental dose of 62.5 mg of MDMA, or they received initial and supplemental doses of
inactive placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Multidisciplinary Association for Psychedelic Studies